| 000 | 01254 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513150809.0 | ||
| 264 | 0 | _c19981005 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1002/j.1552-4604.1998.tb04467.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMant, T | |
| 245 | 0 | 0 |
_aMaximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cJul 1998 |
||
| 300 |
_a610-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhysostigmine _xadministration & dosage |
| 700 | 1 | _aTroetel, W M | |
| 700 | 1 | _aImbimbo, B P | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 38 _gno. 7 _gp. 610-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1552-4604.1998.tb04467.x _zAvailable from publisher's website |
| 999 |
_c9668451 _d9668451 |
||